Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial

Meenu Bajpai, Suresh Kumar, Ashish Maheshwari, Karan Chhabra, Pratibha kale, Amita Gupta, Ashad Narayanan, Ekta Gupta, Nirupama Trehanpati, Chhagan Bihari, Reshu Agarwal, Kamini Gupta, Upendra kumar Gupta, Ankit Bhardwaj, Guresh Kumar, Mojahidul Islam, Ravinder Singh, Pushpa Yadav, Rakhi Maiwall, Shiv Kumar Sarin
doi: https://doi.org/10.1101/2020.10.25.20219337
Meenu Bajpai
1Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suresh Kumar
2Department of Medicine, Lok Nayak Jai Prakash Hospital, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashish Maheshwari
1Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
MD, PDCC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karan Chhabra
2Department of Medicine, Lok Nayak Jai Prakash Hospital, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pratibha kale
3Department of Microbiology, Institute of Liver and Biliary Sciences, New Delhi, India
MD, DNB, MNAMS, DHM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amita Gupta
1Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashad Narayanan
4Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ekta Gupta
5Department of HepatoVirology, Institute of Liver and Biliary Sciences, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nirupama Trehanpati
6Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chhagan Bihari
7Department of Pathology, Institute of Liver and Biliary Sciences, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reshu Agarwal
5Department of HepatoVirology, Institute of Liver and Biliary Sciences, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamini Gupta
1Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Upendra kumar Gupta
1Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ankit Bhardwaj
8Masters Clinical Research, Department of Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, India
BAMS, PGDCR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guresh Kumar
9Department of Research, Institute of Liver and BiliarySciences, New Delhi, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mojahidul Islam
6Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
M.Sc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravinder Singh
6Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
M.Sc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pushpa Yadav
6Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
M.Sc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakhi Maiwall
4Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India
MD, DM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiv Kumar Sarin
4Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India
MD, DM, D.Sc. (Hony.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shivsarin@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The role of convalescent plasma (COPLA) for the treatment of severely ill Corona Virus Disease-2019 is under investigation. We compared the efficacy and safety of convalescent plasma with fresh frozen plasma (FFP) in severe COVID-19 patients.

Methods and findings This was an open-label, single-centre phase II RCT on 29 patients with severe COVID-19 from India. One group received COPLA with standard medical care (SMC) (n=14), and another group received FFP with SMC (n=15). A total of 29 patients were randomized in the two treatment groups. Eleven out of 14 (78.5%) patients remained free of ventilation at day seven in the intervention arm while the proportion was 14 out of 15 (93.3 %) in the control arm (p= 0.258). The median reductions in RR per min at 48-hours in COPLA-group and FFP group were -6.5 and -3 respectively [p=0.004] and at day seven were -14.5 and -10 respectively (p=0.008). The median improvements in percentage O2 saturation at 48-hours were 6.5 and 2 respectively [p=0.001] and at day seven were 10 and 7.5 respectively (p=0.026). In the COPLA-group, the median improvement in PaO2/FiO2 was significantly superior to FFP at 48-hours [41.94 and 231.15, p=0.009], and also at day-7 [5.55 and 77.01 p<0.001]. We did not find significant differences in hospitalization duration between the groups (0.08).

Conclusion COPLA therapy resulted in rapid improvement in respiratory parameters and shortened time to clinical recovery, although no significant reduction in mortality was observed in this pilot trial. We need larger trials to draw conclusive evidence on the use of Convalescent plasma in COVID-19. This trial is registered with ClinicalTrial.gov (identifier: NCT04346446).

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04346446

Funding Statement

No external funding was received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of Institute of Liver and Biliary Sciences, and IRB of Maulana Azad Medical College

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available with Project Investigators at Institute of Liver and Biliary Sciences, and Maulana Azad Medical College and will be available with permission of IRB of above institute

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 27, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial
Meenu Bajpai, Suresh Kumar, Ashish Maheshwari, Karan Chhabra, Pratibha kale, Amita Gupta, Ashad Narayanan, Ekta Gupta, Nirupama Trehanpati, Chhagan Bihari, Reshu Agarwal, Kamini Gupta, Upendra kumar Gupta, Ankit Bhardwaj, Guresh Kumar, Mojahidul Islam, Ravinder Singh, Pushpa Yadav, Rakhi Maiwall, Shiv Kumar Sarin
medRxiv 2020.10.25.20219337; doi: https://doi.org/10.1101/2020.10.25.20219337
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial
Meenu Bajpai, Suresh Kumar, Ashish Maheshwari, Karan Chhabra, Pratibha kale, Amita Gupta, Ashad Narayanan, Ekta Gupta, Nirupama Trehanpati, Chhagan Bihari, Reshu Agarwal, Kamini Gupta, Upendra kumar Gupta, Ankit Bhardwaj, Guresh Kumar, Mojahidul Islam, Ravinder Singh, Pushpa Yadav, Rakhi Maiwall, Shiv Kumar Sarin
medRxiv 2020.10.25.20219337; doi: https://doi.org/10.1101/2020.10.25.20219337

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)